Concepts (55)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Dopamine D1 | 5 | 2006 | 14 | 0.770 |
Why?
|
| Academic Success | 1 | 2021 | 8 | 0.710 |
Why?
|
| Students | 1 | 2021 | 120 | 0.630 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 5 | 2006 | 9 | 0.350 |
Why?
|
| GTP-Binding Proteins | 2 | 2006 | 9 | 0.300 |
Why?
|
| Cyclic N-Oxides | 2 | 2006 | 7 | 0.300 |
Why?
|
| Hyperglycemia | 2 | 2006 | 10 | 0.290 |
Why?
|
| Obesity | 3 | 2005 | 115 | 0.290 |
Why?
|
| Oxidative Stress | 2 | 2006 | 58 | 0.280 |
Why?
|
| Dopamine Agonists | 3 | 2005 | 9 | 0.280 |
Why?
|
| Natriuresis | 2 | 2006 | 9 | 0.270 |
Why?
|
| Kidney Tubules | 1 | 2006 | 5 | 0.240 |
Why?
|
| Antioxidants | 1 | 2006 | 23 | 0.240 |
Why?
|
| Natriuretic Agents | 1 | 2003 | 1 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2003 | 9 | 0.210 |
Why?
|
| Insulin | 4 | 2006 | 29 | 0.180 |
Why?
|
| Teaching | 1 | 2021 | 11 | 0.180 |
Why?
|
| Faculty | 1 | 2021 | 15 | 0.180 |
Why?
|
| Rats | 5 | 2006 | 241 | 0.180 |
Why?
|
| Educational Measurement | 1 | 2021 | 49 | 0.170 |
Why?
|
| Retrospective Studies | 1 | 2021 | 341 | 0.160 |
Why?
|
| Blood Glucose | 4 | 2006 | 29 | 0.140 |
Why?
|
| Animals | 5 | 2006 | 1711 | 0.120 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2006 | 17 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 125 | 0.110 |
Why?
|
| Male | 5 | 2006 | 2491 | 0.110 |
Why?
|
| Kidney | 2 | 2005 | 51 | 0.110 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2004 | 27 | 0.100 |
Why?
|
| Rats, Zucker | 3 | 2005 | 20 | 0.080 |
Why?
|
| Spin Labels | 2 | 2006 | 7 | 0.080 |
Why?
|
| Humans | 1 | 2021 | 4936 | 0.080 |
Why?
|
| Protein Kinase C | 2 | 2006 | 15 | 0.070 |
Why?
|
| Sodium | 2 | 2004 | 12 | 0.060 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2006 | 3 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 2 | 0.060 |
Why?
|
| Drinking | 1 | 2006 | 4 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2006 | 4 | 0.060 |
Why?
|
| Streptozocin | 1 | 2006 | 6 | 0.060 |
Why?
|
| beta-Adrenergic Receptor Kinases | 1 | 2006 | 6 | 0.060 |
Why?
|
| Body Weight | 1 | 2006 | 58 | 0.060 |
Why?
|
| Protein Binding | 1 | 2006 | 115 | 0.060 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2004 | 2 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2004 | 4 | 0.050 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2003 | 3 | 0.050 |
Why?
|
| Hyperinsulinism | 1 | 2003 | 6 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 24 | 0.050 |
Why?
|
| Malondialdehyde | 1 | 2005 | 2 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 48 | 0.010 |
Why?
|
| Colforsin | 1 | 2004 | 4 | 0.010 |
Why?
|
| Urine | 1 | 2004 | 4 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2004 | 6 | 0.010 |
Why?
|
| Dopamine | 1 | 2004 | 26 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 30 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 225 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2004 | 48 | 0.010 |
Why?
|